🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment

Recruitingn/aAges 18 Years - 45 YearsFemaleNational University of Malaysia
NCT05326204 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A study to compare between 1 and 2 hours post meal blood glucose monitoring in patients with Gestational Diabetes Mellitus requiring treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline * requiring treatment either with metformin alone or combined with insulin Exclusion Criteria: * type 1 and 2 diabetes * bad obstetrics history * underlying medical disorders such as Systemic Lupus Erythematosus * fetal anomaly * delivery elsewhere
💊

What it tests

  • Home blood glucose monitoring
📍

Where

1 site
UKM Medical Center
Kuala Lumpur, Malaysia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy